Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.
Bayer Dividend Announcement
• Bayer announced a annually dividend of $0.02 per ordinary share which will be made payable on 2024-05-13. Ex dividend date: 2024-04-29
• Bayer annual dividend for 2024 was $0.02
• Bayer annual dividend for 2023 was $0.70
• Bayer's trailing twelve-month (TTM) dividend yield is 0.43%
• Bayer's payout ratio for the trailing twelve months (TTM) is -9.48%
• Bayer's dividend growth over the last five years (2018-2023) was -10.74% year
• Bayer's dividend growth over the last ten years (2013-2023) was -14.18% year
Bayer Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-04-29 | $0.02 | annually | 2024-05-13 |
2023-05-02 | $0.70 | annually | 2023-05-15 |
2022-05-02 | $0.55 | annually | 2022-05-16 |
2021-04-28 | $0.59 | annually | 2021-05-10 |
2020-04-29 | $0.77 | annually | 2020-05-14 |
2019-04-29 | $0.79 | annually | 2019-05-13 |
2018-06-22 | $0.42 | annually | 2018-07-02 |
2018-05-25 | $0.81 | annually | 2018-06-11 |
2017-05-01 | $3.14 | annually | 2017-05-15 |
2016-04-27 | $3.21 | annually | 2016-05-12 |
2015-05-22 | $2.83 | annually | 2015-06-08 |
2014-04-25 | $3.99 | annually | 2014-05-12 |
2013-04-24 | $3.22 | annually | 2013-05-09 |
Bayer Dividend per year
Bayer Dividend growth
Bayer Dividend Yield
Bayer current trailing twelve-month (TTM) dividend yield is 0.43%. Interested in purchasing Bayer stock? Use our calculator to estimate your expected dividend yield:
Bayer Financial Ratios
Bayer Dividend FAQ
Other factors to consider when evaluating Bayer as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Bayer stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Bayer's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Bayer publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Bayer distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Bayer are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Bayer sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Bayer distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Bayer declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Bayer's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Bayer's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.